| Particulars |
|
|
|
| Company Name
| Sanofi India Ltd
| Year End
| 202512
|
| Full Year |
| Equity (₹ Cr.) |
23.03 |
B.V. (₹) |
325.30 |
| Sales(₹ Cr.) |
1,837.40 |
NP (₹ Cr.) |
346.46 |
| NP Var% |
-22.00 |
Div% |
1,230.00 |
| CPS(₹) |
166.60 |
EPS (₹) |
150.40 |
| Traded Value(₹ Lakhs) |
86.88 |
52 Week High |
6,718.00 |
| 52 Week Low |
3,151.00 |
Price BSE |
3,349.00 |
| Price NSE |
3,340.00 |
Market Capital (₹ Cr.) |
7,713.67 |
| P/C Ratio |
20.10 |
P/E Ratio |
22.30 |
| Price Vs.BV |
10.30 |
|
| Latest Quarter |
| Year End |
202512 |
Sales (₹ Cr.) |
419.80 |
| NP(₹ Cr.) |
61.70 |
NP Var % |
-28.00 |
| Trailing Twelve Months |
| Year End |
202512 |
Sales |
2,192.20 |
| OPM |
24.70 |
NP |
421.55 |
| NP Var% |
-21.66 |
EPS |
150.44 |
| PE |
22.26 |
|
|